Cardiac Medications

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 183 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Pharmacology for the Clinical Chemist: Therapeutic Drug Monitoring and Pharmacogenomics. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Pharmacology for the Clinical Chemist: Therapeutic Drug Monitoring and Pharmacogenomics (online CE course)
Cardiac Medications

Inotropics (drugs used to increase the pumping ability of the heart) and antiarrhythmics may need TDM. The cardiac glycoside inotropics digoxin and digitoxin have narrow therapeutic windows. Overdose can cause vomiting, diarrhea, confusion, visual disturbances, and cardiac arrhythmias. An interesting conundrum regarding these medications is that an overdose will produce the same symptoms that the drug is used to treat. For example, procainamide is used for arrhythmia, but an overdose of procainamide can produce an arrhythmia. Thus, without TDM, the physician will not know whether to give more or less drugs since both states can lead to the same presentation.
Examples of cardiac medications that are monitored by TDM include:
  • Digoxin
  • Digitoxin
  • Procainamide
  • N-acetylprocainamide (NAPA) -the metabolite of procainamide
  • Quinidine